Mei Xue

4.5k total citations · 1 hit paper
116 papers, 3.4k citations indexed

About

Mei Xue is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Mei Xue has authored 116 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 16 papers in Epidemiology and 16 papers in Immunology. Recurrent topics in Mei Xue's work include Animal Virus Infections Studies (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Autophagy in Disease and Therapy (9 papers). Mei Xue is often cited by papers focused on Animal Virus Infections Studies (10 papers), Viral gastroenteritis research and epidemiology (9 papers) and Autophagy in Disease and Therapy (9 papers). Mei Xue collaborates with scholars based in China, United States and Australia. Mei Xue's co-authors include Liming Chen, Bei Sun, Ying Cheng, Yunhong Lu, Xiaochen Yu, Fei Han, Linxin Xu, Yunpeng Chang, Xiangyang Liu and Xiaoyu Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mei Xue

106 papers receiving 3.3k citations

Hit Papers

SGLT2 inhibition with empagliflozin attenuates myocardial... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
    2019 442 citations Mei Xue, Xiaoyu Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei Xue China 32 1.4k 573 541 480 438 116 3.4k
Mei Zhu China 38 1.7k 1.2× 276 0.5× 397 0.7× 313 0.7× 371 0.8× 117 4.1k
Li Kang China 31 1.8k 1.3× 303 0.5× 323 0.6× 392 0.8× 757 1.7× 81 4.2k
Takuya Awata Japan 44 2.3k 1.6× 463 0.8× 1.4k 2.6× 1.4k 2.9× 575 1.3× 163 6.4k
Ruth Rasch Denmark 35 1.0k 0.7× 566 1.0× 829 1.5× 396 0.8× 99 0.2× 64 4.2k
Markku Lehto Finland 38 2.3k 1.6× 194 0.3× 778 1.4× 1.6k 3.4× 552 1.3× 96 4.9k
Noriyuki Sonoda Japan 32 1.9k 1.3× 418 0.7× 874 1.6× 692 1.4× 534 1.2× 58 4.5k
Tadashi Yamakawa Japan 35 1.3k 0.9× 718 1.3× 724 1.3× 542 1.1× 609 1.4× 95 3.9k
Hui‐Young Lee South Korea 37 3.1k 2.2× 369 0.6× 1.1k 2.0× 1.1k 2.3× 1.4k 3.2× 122 6.3k
Yanfei Qi China 29 2.4k 1.7× 906 1.6× 561 1.0× 403 0.8× 337 0.8× 92 4.4k

Countries citing papers authored by Mei Xue

Since Specialization
Citations

This map shows the geographic impact of Mei Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei Xue more than expected).

Fields of papers citing papers by Mei Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei Xue. The network helps show where Mei Xue may publish in the future.

Co-authorship network of co-authors of Mei Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Mei Xue. A scholar is included among the top collaborators of Mei Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei Xue. Mei Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Ting, et al.. (2025). Canagliflozin ameliorates diabetic podocyte damage via enriching mitochondria-associated endoplasmic reticulum membranes. Cellular Signalling. 135. 112038–112038. 1 indexed citations
2.
Zhang, Ye, Chen Li, Yilin Ji, et al.. (2025). Machine Learning-Based Mortality Risk Prediction Model in Patients with Sepsis. Journal of Inflammation Research. Volume 18. 6427–6437. 1 indexed citations
3.
Li, Hong, Yujuan Liu, Mei Xue, et al.. (2024). Variation in phytotoxicity of rice seedlings caused by differential accumulation of azoxystrobin and pyraclostrobin in leaves. Plant Physiology and Biochemistry. 215. 108947–108947. 4 indexed citations
4.
5.
6.
7.
Wang, Xian, et al.. (2023). Efficacy of Danggui Buxue decoction on diabetic nephropathy-induced renal fibrosis in rats and possible mechanism.. PubMed. 43(3). 507–513. 5 indexed citations
8.
Shadman, Mazyar, Alessandra Tedeschi, Nicole Lamanna, et al.. (2023). Similar Efficacy of Ibrutinib Arms across ALPINE and ELEVATE-RR Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison. Blood. 142(Supplement 1). 4655–4655. 1 indexed citations
9.
Yu, Xiaochen, Ziyu Meng, Ting Fang, et al.. (2022). Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway. Frontiers in Physiology. 13. 817542–817542. 12 indexed citations
10.
Zhao, Liyuan, Liang Li, Mei Xue, et al.. (2022). Gasdermin D Inhibits Coronavirus Infection by Promoting the Noncanonical Secretion of Beta Interferon. mBio. 13(1). e0360021–e0360021. 15 indexed citations
11.
Li, Ting, Ting Fang, Linxin Xu, et al.. (2021). Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro. Frontiers in Pharmacology. 11. 622153–622153. 21 indexed citations
12.
Xue, Mei, Ting Fang, Ying Cheng, et al.. (2021). PACS-2 attenuates diabetic kidney disease via the enhancement of mitochondria-associated endoplasmic reticulum membrane formation. Cell Death and Disease. 12(12). 729–740. 42 indexed citations
13.
Chen, Jianjun, Xiaojia Wu, Lü Chen, et al.. (2020). Analysing the Clinical Features of Pneumomediastinum Associated with Diabetic Ketoacidosis in 79 Cases. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Zhang, Wei, Jian Chen, Xin Wu, et al.. (2020). Preoperative Ultra-Short-Course Chemotherapy Combined with Surgery for the Treatment of Chest Wall Tuberculosis. SHILAP Revista de lepidopterología.
15.
Xue, Mei, Yuyi Zhang, Hui Zhu, et al.. (2020). Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, China. American Journal of Infection Control. 48(9). 1045–1050. 22 indexed citations
16.
Xue, Mei, Ting Li, Yue Wang, et al.. (2019). Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice. Clinical Science. 133(15). 1705–1720. 85 indexed citations
17.
Xue, Mei, Ying Cheng, Fei Han, et al.. (2018). Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease. International Journal of Biological Sciences. 14(11). 1545–1557. 93 indexed citations
18.
Chang, Yunpeng, Bei Sun, Zhe Han, et al.. (2017). Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy. Frontiers in Pharmacology. 8. 28 indexed citations
19.
Vines, Charlotte M., et al.. (2002). Regulation of N -Formyl Peptide-Mediated Degranulation by Receptor Phosphorylation. The Journal of Immunology. 169(12). 6760–6766. 18 indexed citations
20.
Z, Liu, et al.. (2000). [Is Gly460Trp variant of alpha-adducin associated with essential hypertension in the Hans of Chinese population].. PubMed. 17(6). 413–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Zhu Breakdown of academic impact, for papers by Li Kang Breakdown of academic impact, for papers by Takuya Awata Breakdown of academic impact, for papers by Ruth Rasch Breakdown of academic impact, for papers by Markku Lehto Breakdown of academic impact, for papers by Noriyuki Sonoda Breakdown of academic impact, for papers by Tadashi Yamakawa Breakdown of academic impact, for papers by Hui‐Young Lee Breakdown of academic impact, for papers by Yanfei Qi
Rankless by CCL
2026